PALI: Palisade Bio, Inc. Stock

by  •  • Comments Off on PALI: Palisade Bio, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 3.08
Enterprise Value ($M) -6.66
Book Value ($M) 7.49
Book Value / Share 1.70
Price / Book 0.41
NCAV ($M) 7.11
NCAV / Share 1.62
Price / NCAV 0.43

Profitability (mra)
Return on Invested Capital (ROIC) -1.88
Return on Assets (ROA) -1.14
Return on Equity (ROE) -1.43

Liquidity (mrq)
Quick Ratio 3.24
Current Ratio 3.24

Balance Sheet (mrq) ($M)
Current Assets 10.49
Assets 10.88
Liabilities 3.39
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -14.86
Net Income -14.44
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -12.19
Cash from Investing 0.00
Cash from Financing 9.58

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Armistice Capital, Llc 9.99 127.08

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-24 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 5,507 46,167 11.93
2025-04-16 700 28,746 2.44
2025-04-15 3,320 29,332 11.32

(click for more detail)

Similar Companies
ORGO – Organogenesis Holdings Inc. ORMP – Oramed Pharmaceuticals Inc.
OTLK – Outlook Therapeutics, Inc. PASG – Passage Bio, Inc.
PCSA – Processa Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io